GANX (GANX) Stock Price & Analysis
GANX (GANX) rose 0.00% to USD 1.75 as of July 26, 2026 at 12:48 UTC, according to Nexqual real-time market data.
GANX last closed at USD 1.75; the session ranged USD 1.74–1.81 on volume of 471,686 shares. Market capitalization is —, with a 52-week range of USD 1.41–4.34 (NGM). Source: Nexqual, July 26, 2026 at 12:48 UTC.
Key Statistics (as of July 26, 2026 at 12:48 UTC)
| Price | USD 1.75 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 1.75 |
| Open | USD 1.75 |
| Day Range | USD 1.74 – 1.81 |
| 52-Week Range | USD 1.41 – 4.34 |
| Volume | 471,686 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (GANX)
Nexqual's technical model rates GANX "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 12:48 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 49.02 (neutral) |
| vs SMA50 | Below (USD 1.78) |
| MACD | -0.01 (negative) |
From GANX's Latest SEC 10-K Filing (filed 2026-03-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FNCHQ | Finch Therapeutics Group, Inc. | USD 10 | ▲ 0% |
| CNTB | Connect Biopharma Holdings Limi | USD 2.14 | ▼ 2.73% |
| HOWL | Werewolf Therapeutics, Inc. | USD 0.43 | ▲ 16.99% |
| INAB | IN8bio, Inc. | USD 1.2 | ▼ 2.44% |
| COYA | Coya Therapeutics, Inc. | USD 4.25 | ▼ 2.75% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 12:48 UTC. This page is informational and not investment advice.